Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group-Reference-Cited by-同舟云学术

Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group

Published:2023-03 Issue: Volume:180 Page:109460
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Ka Kanta,Schiappa Renaud,Terlizzi Mario,Mallet Frederic,Martin Etienne,Chand Marie-Eve,Demogeot Nicolas,Peiffert Didier,Pommier Pascal,Quivrin Magali,Kissel Manon,Pasquier Corentin,Khalifa Jonathan,Bossi Alberto,Hannoun-Levi Jean-Michel,Blanchard Pierre

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference30 articles.

1. ASCENDE-RT: an analysis of health-related quality of life for a randomized trial comparing low-dose-rate brachytherapy boost with dose-escalated external beam boost for high- and intermediate-risk prostate cancer;Rodda;Int J Radiat Oncol Biol Phys,2017

2. Prostate cancer external beam radiotherapy;de Crevoisier;Cancer Radiother J Soc Francaise Radiother Oncol,2016

3. Brachytherapy for patients with prostate cancer: american society of clinical oncology/cancer care ontario joint guideline update;Chin;J Clin Oncol,2017

4. ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer;Rodda;Int J Radiat Oncol Biol Phys,2017

5. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer;Hoskin;Radiother Oncol J Eur Soc Ther Radiol Oncol,2012